MoneyWorks4Me

Dr. Reddy’s Laboratories informs about press release

05 Jun 2023 Evaluate

Dr. Reddy’s Laboratories has informed that it enclosed a press release titled ‘Dr. Reddy’s successfully completes Phase I study (IV route) of DRL_TC, a proposed biosimilar of tocilizumabp’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.75
Dr. Reddys Labs. 1152.00
Cipla 1353.35
Lupin 2069.40
Zydus Lifesciences 1111.00
View more..